SPHINGO- AND PHOSPHO-LIPIDS METABOLISM IMPAIRMENT AS A POTENTIAL THERAPEUTIC TARGET IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY

被引：0
|
作者：
Capodivento, G. [1 ,2 ]
Visigalli, D. [1 ,2 ]
Basit, A. [3 ]
Pastore, V. P. [4 ]
Armirotti, A. [3 ]
Schenone, A. [1 ,2 ]
Nobbio, L. [1 ,2 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
[2] Univ Genoa, CEBR, Genoa, Italy
[3] Ist Italiano Tecnol IIT, Drug Discovery & Dev Dept, Genoa, Italy
[4] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn DIBRIS, Genoa, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [31] Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease
    José Gazulla
    Carmen Almárcegui
    José Berciano
    Neurological Sciences, 2018, 39 : 793 - 794
  • [32] Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease
    Gazulla, Jose
    Almarcegui, Carmen
    Berciano, Jose
    NEUROLOGICAL SCIENCES, 2018, 39 (04) : 793 - 794
  • [33] LINKAGE OF CHARCOT-MARIE-TOOTH NEUROPATHY TYPE 1A TO CHROMOSOME-17
    VANCE, JM
    NICHOLSON, GA
    YAMAOKA, LH
    STAJICH, J
    STEWART, CS
    SPEER, MC
    HUNG, WY
    BARKER, DF
    GASKELL, PC
    ROSES, AD
    PERICAKVANCE, MA
    CYTOGENETICS AND CELL GENETICS, 1989, 51 (1-4): : 1097 - 1098
  • [34] P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A)
    Nobbio, L.
    Visigalli, D.
    Mannino, E.
    Fiorese, F.
    Pareyson, D.
    Sereda, M. W.
    Prada, V
    Mancardi, G. L.
    Zocchi, E.
    Bruzzone, S.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 22 - 22
  • [35] DEPRESSION IN PATIENTS WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A): FINDINGS FROM A REAL-WORLD DIGITAL STUDY
    Thomas, Florian
    Sevilla, Teresa
    Sivera, Rafael
    Genovese, Filippo
    Gray, Amy
    Bull, Simon
    Paoli, Xavier
    Senechal, Thomas
    Day, Laura
    Llewellyn, Samuel
    Larkin, Mark
    Boutalbi, Youcef
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S16 - S16
  • [36] Comparison of Charcot-Marie-Tooth neuropathy type 2 and type 1A: clinical characteristics
    Nikodinovic, J.
    Rasic, V. Milic
    Mladenovic, J.
    JOURNAL OF NEUROLOGY, 2010, 257 : S107 - S107
  • [37] Molecular detection of Charcot-Marie-Tooth 1a (CMT1A) duplication in Mexicam patients by quantitative gene scan technology
    Arenas-Sordo, ML
    Hernández-Zamora, E
    González-Huerta, NC
    Maldonado-Rodríguez, R
    Leyva-García, N
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 682 - 682
  • [38] Axon-glia metabolic coupling of peripheral nerves in a rodent model of Charcot-Marie-Tooth 1A (CMT1A)
    Linhoff, L.
    Kungl, T.
    Hermes, D.
    van Dort, J.
    Maack, C.
    Fledrich, R.
    Willig, K.
    Hiller, K.
    Nave, K. A.
    Sereda, M. W.
    GLIA, 2019, 67 : E283 - E283
  • [39] Overview of Charcot-Marie-Tooth disease type 1A
    Thomas, PK
    CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 1 - 5
  • [40] Preimplantation diagnosis for Charcot-Marie-Tooth type 1A
    Löfgren, A
    De Vos, A
    Sermon, K
    Liebaers, I
    Van Steirteghem, A
    Van Broeckhoven, C
    CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 460 - 462
12345